Abstract GS1-07: Results from a Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating Adjuvant Endocrine Therapy +/- 1 Year of Everolimus in Patients with High-Risk Hormone Receptor-Positive, HER2-negative Breast Cancer: SWOG S1207
Cancer Research（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined